Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Smith & Nephew plc before investing.

In this article, we go over a few key elements for understanding Smith & Nephew plc’s stock price such as:

• Smith & Nephew plc’s current stock price and volume
• Why Smith & Nephew plc’s stock price changed recently
• Upgrades and downgrades for SNN from analysts
• SNN’s stock price momentum as measured by its relative strength

About Smith & Nephew plc (SNN)

Before we jump into Smith & Nephew plc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Want to learn more about Smith & Nephew plc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Smith & Nephew plc.

Smith & Nephew plc’s Stock Price as of Market Close

As of April 30, 2025, 12:47 PM, CST, Smith & Nephew plc’s stock price was $28.110.

Smith & Nephew plc is up 4.42% from its previous closing price of $26.920.

During the last market session, Smith & Nephew plc’s stock traded between $27.960 and $28.650. Currently, there are approximately 872.53 million shares outstanding for Smith & Nephew plc.

Smith & Nephew plc’s price-earnings (P/E) ratio is currently at 57.3, which is high compared to the Health Care Equipment & Supplies industry median of 32. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Smith & Nephew plc Stock Price History

Smith & Nephew plc’s (SNN) price is currently down 0.92% so far this month.

During the month of April, Smith & Nephew plc’s stock price has reached a high of $28.830 and a low of $23.910.

Over the last year, Smith & Nephew plc has hit prices as high as $31.720 and as low as $23.690. Year to date, Smith & Nephew plc’s stock is up 14.36%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Smith & Nephew plc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 29, 2025, there were analysts who downgraded Smith & Nephew plc’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Smith & Nephew plc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Smith & Nephew plc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Smith & Nephew plc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Smith & Nephew plc (SNN) by visiting AAII Stock Evaluator.

Relative Price Strength of Smith & Nephew plc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 29, 2025, Smith & Nephew plc has a weighted four-quarter relative price strength of 3.88%, which translates to a Momentum Score of 69 and is considered to be Strong.

Want to learn more about how Smith & Nephew plc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Smith & Nephew plc Stock Price: Bottom Line

As of April 30, 2025, Smith & Nephew plc’s stock price is $28.110, which is up 4.42% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Smith & Nephew plc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.